Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2005-11-10
2009-02-24
Zucker, Paul A (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C540S075000, C549S390000, C560S009000, C560S231000
Reexamination Certificate
active
07495029
ABSTRACT:
Disclosed are prodrugs of (2R)-2-propyloctanoic acid, and pharmaceutical compositions comprising them, which may be effective in modulating multiple events in the biochemical cascade of stroke. Also disclosed are methods of treating patients who have had a stroke, or are at risk of stroke, by administering the compounds or compositions of the invention.
REFERENCES:
patent: 4791207 (1988-12-01), Salzmann et al.
patent: 5641792 (1997-06-01), Kleemann et al.
patent: 5733909 (1998-03-01), Black et al.
patent: 5849943 (1998-12-01), Atkinson et al.
patent: 5925631 (1999-07-01), Black et al.
patent: 6020343 (2000-02-01), Belley et al.
patent: 6057319 (2000-05-01), Black et al.
patent: 6201021 (2001-03-01), Ohuchida et al.
patent: 6608221 (2003-08-01), Toda et al.
patent: 2006016318 (2006-01-01), None
Munoz Benito
Payne Joseph E.
Prasit Petpiboon
Reger Thomas S.
Smith Nicholas D.
Krovatin William
Merck & Co. Inc
Todaro John C.
Zucker Paul A
LandOfFree
Prodrugs of (2R)-2-propyloctanoic acid for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prodrugs of (2R)-2-propyloctanoic acid for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prodrugs of (2R)-2-propyloctanoic acid for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4054610